• Most ‘threshold’ recommendations for preprocedural platelet transfusions are based on low quality evidence or opinion. Existing data suggest no linear relationship between platelet count and risk of spontaneous bleeding. • Given the risks associated with platelet transfusion, alternatives should be considered: desmopressin and antifibrinolytic agents in the acute setting and thrombopoietin receptor agonists for select groups in the elective setting.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile